The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer …, 2023 - Wiley Online Library
Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study.
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer …, 2023 - search.ebscohost.com
Background: How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer …, 2023 - search.proquest.com
Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
Japanese Dyspnea Relief Investigators - Cancer …, 2023 - tohoku.elsevierpure.com
Background: How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
[HTML][HTML] The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer …, 2023 - ncbi.nlm.nih.gov
Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer Medicine, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
How clinicians treat patients with terminal dyspnea widely varies, which could hamper …
How clinicians treat patients with terminal dyspnea widely varies, which could hamper …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
M Mori, T Yamaguchi, K Suzuki… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study.
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer …, 2022 - europepmc.org
Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
[引用][C] The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A? multicenter cohort study
森雅紀， 山口崇， 松沼亮 - Cancer Medicine, 2022 - cir.nii.ac.jp
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with
terminal dyspnea: A?multicenter cohort study | CiNii Research CiNii 国立情報学研究所 学術 …
terminal dyspnea: A?multicenter cohort study | CiNii Research CiNii 国立情報学研究所 学術 …
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study.
M Mori, T Yamaguchi, K Suzuki, Y Matsuda… - Cancer …, 2022 - europepmc.org
Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …